Abstract
Objective To observe the clinical effect of the combined use of Shenqiwuweizi tablet and Shensongyangxin capsule in auricular fibrillation (AF) conversion and its safety. Methods 200 patients, in whom AF lasted for less than 1year, were enrolled and randomly assigned into two groups, patients in the treatment group (n=113) were treated with Shenqiwuweizi tablet and Shensongyangxin capsule and the others in the control group (n=87) were orally administered with amiodaron alone. Both were orally administered with folic acid, vitamin B6, B12, aspirin enteric-coated to anti thromboembolism.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
